Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice

Experimental Neurology

Volumn 201, Issue 1, 2006, Pages 120-130

  Pardo, Andrea C ^a   Wong, Victor ^a   Benson, Leah M ^a   Dykes, Margaret ^a   Tanaka, Kohichi ^b   Rothstein, Jeffrey D ^a   Maragakis, Nicholas J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; LUMBAR SPINAL CORD; MOTOR NEURON DISEASE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SURVIVAL;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ANTERIOR HORN CELLS; ASTROCYTES; EXCITATORY AMINO ACID TRANSPORTER 1; FEMALE; GENOTYPE; HUMANS; IMMUNOBLOTTING; LUMBOSACRAL REGION; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR NEURON DISEASE; MOTOR NEURONS; MUTATION; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 33747101645     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.03.028     Document Type: Article

References (38)

1. Alexander G.M., Deitch J.S., Seeburger J.L., Del Valle L., and Heiman-Patterson T.D. Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase. J. Neurochem. 74 (2000) 1666-1673
2. Bendotti C., Tortarolo M., Suchak S.K., Calvaresi N., Carvelli L., Bastone A., Rizzi M., Rattray M., and Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem. 79 (2001) 737-746
3. Bristol L.A., and Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39 (1996) 676-679
4. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., and Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18 (1997) 327-338
5. Clement A.M., Nguyen M.D., Roberts E.A., Garcia M.L., Boillee S., Rule M., McMahon A.P., Doucette W., Siwek D., Ferrante R.J., Brown Jr. R.H., Julien J.P., Goldstein L.S., and Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302 (2003) 113-117
6. Cleveland D.W., and Rothstein J.D. From charcot to lou gehrig: deciphering selective motor neuron death in als. Nat. Rev., Neurosci. 2 (2001) 806-819
7. Crino P.B., Jin H., Shumate M.D., Robinson M.B., Coulter D.A., and Brooks-Kayal A.R. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43 (2002) 211-218
8. Dal Canto M.C., and Gurney M.E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145 (1994) 1271-1280
9. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., and Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52 (2002) 771-778
10. Dunlop J., Beal M.H., She Y., and Howland D.S. Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis. J. Neurosci. 23 (2003) 1688-1696
11. Flowers J.M., Powell J.F., Leigh P.N., Andersen P., and Shaw C.E. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann. Neurol. 49 (2001) 643-649
12. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., and Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20 (2000) 660-665
13. Guo H., Lai L., Butchbach M.E., Stockinger M.P., Shan X., Bishop G.A., and Lin C.L. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum. Mol. Genet. 12 (2003) 2519-2532
14. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.-X., Chen W., Zhai P., Sufit R.L., and Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
15. Gurney M.E., Cuttings F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., and Hall E.D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39 (1996) 147-157
16. Heiman-Patterson T.D., Deitch J.S., Blankenhorn E.P., Erwin K.L., Perreault M.J., Alexander B.K., Byers N., Toman I., and Alexander G.M. Background and gender effects on survival in the TgN (SOD1-G93A)1Gur mouse model of ALS. J. Neurol. Sci. (2005)
17. Honig L.S., Chambliss D.D., Bigio E.H., Carroll S.L., and Elliott J.L. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology 55 (2000) 1082-1088
18. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1604-1609
19. Kuner R., Groom A.J., Bresink I., Kornau H.C., Stefovska V., Muller G., Hartmann B., Tschauner K., Waibel S., Ludolph A.C., Ikonomidou C., Seeburg P.H., and Turski L. Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc. Natl. Acad. Sci. U. S. A. (2005)
20. Lino M.M., Schneider C., and Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22 (2002) 4825-4832
21. Liu J., Lillo C., Jonsson P.A., Vande V.C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., Brannstrom T., Gredal O., Wong P.C., Williams D.S., and Cleveland D.W. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43 (2004) 5-17
22. Maragakis N.J., and Rothstein J.D. Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis. 15 (2004) 461-473
23. Maragakis N.J., Dykes-Hoberg M., and Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 55 (2004) 469-477
24. Mathern G.W., Mendoza D., Lozada A., Pretorius J.K., Dehnes Y., Danbolt N.C., Nelson N., Leite J.P., Chimelli L., Born D.E., Sakamoto A.C., Assirati J.A., Fried I., Peacock W.J., Ojemann G.A., and Adelson P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52 (1999) 453-472
25. Meyer T., Fromm A., Munch C., Schwalenstocker B., Fray A.E., Ince P.G., Stamm S., Gron G., Ludolph A.C., and Shaw P.J. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 170 (1999) 45-50
26. Mitani A., and Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23 (2003) 7176-7182
27. Pardo C.A., Xu Z., Borchelt D.R., Price D.L., Sisodia S.S., and Cleveland D.W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 954-958
28. Pramatarova A., Laganiere J., Roussel J., Brisebois K., and Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21 (2001) 3369-3374
29. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., and Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28 (1990) 18-25
30. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., and Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 13 (1994) 713-725
31. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
32. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J., and Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
33. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes H.M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., and Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 (2005) 73-77
34. Tanaka K. Epilepsy and exacerbation of brain injury in mice lacking glutamate transporter GLT-1 (Vol 276, pg 1699, 1997). Science 278 (1997) 21
35. Tao F., Lu S.D., Zhang L.M., Huang Y.L., and Sun F.Y. Role of excitatory amino acid transporter 1 in neonatal rat neuronal damage induced by hypoxia-ischemia. Neuroscience 102 (2001) 503-513
36. Trotti D., Rolfs A., Danbolt N.C., Brown Jr. R.H., and Hediger M.A. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter [In Process Citation]. Nat. Neurosci. 2 (1999) 427-433
37. Van Damme P., Leyssen M., Callewaert G., Robberecht W., and Van Den B.L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci. Lett. 343 (2003) 81-84
38. Watanabe T., Morimoto K., Hirao T., Suwaki H., Watase K., and Tanaka K. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res. 845 (1999) 92-96